Scientific Board

Process Analytical Technology is one of the most exciting and important advanced technology areas meeting both the current challenges, as well as the future needs of industry. Since 1987, the IFPAC conferences have generated the enthusiastic response that resulted in the creation of a series of International meetings featuring the regulators, manufacturers, researchers and industry users.  Equipment and services are typically on display during our events.

So please join with your colleagues...the people who are the foundation of Process Analytical Technology (PAT), QbD, Process Understanding & Control, and Real-Time Analytics. Come share in discussions, give input and get ideas for the future well-being of the industry.




Robert Guenard, Biogen, RTP, NC

Thomas O'Connor, FDA, CDER, OPQ, OTR, DPQR, Silver Spring, MD

Ryan Simpson, Eastman Chemical Company, Kingsport, TN



Christian Airiau, Sanofi, Framingham, MA
Ahmad Almaya, Eli Lilly, Indianapolis, IN
Scott Armstrong, Phillips 66, Houston, TX
Bob Bear, Ametek, Pittsburgh, PA
Lucinda Buhse, FDA, CDER, OPQ, OTR, DPA, Silver Spring, MD
Sharmista Chatterjee, FDA, CDER, OPQ, OPF, Silver Spring, MD
James Cheney, Celgene, Summit, NJ
Greg Connelly, Vertex, Boston, MA
Celia Cruz, Eli Lilly, Indianapolis, IN
Lawrence De Belder, Janssen, Beerse, Belgium
Rick Friedman, FDA, CDER, OC, OMQ, Silver Spring, MD
Neal Gallagher, Eigenvector Research, Inc., Manson, WA
Steve Hammond, Consultant
Walter Henslee, JPAC, McDade, TX
Ernie Hillier, EJH Consulting
David Keire, FDA, CDER, OPQ, OTR, Silver Spring, MD
Mel Koch, APL, Univ. of Washington, Seattle, WA
Evdokia Korakianiti, EMA
Theodora Kourti, Consultant
Steve Kozlowski, FDA, CDER, OPQ, OBP, Silver Spring, MD
Bogdan Kurtyka, FDA, CDER, OPQ, OPF, Silver Spring, MD
Sau (Larry) Lee, FDA,CDER,OMPT,CDER,OPQ,SS, Silver Spring, MD
Lorenz Liesum, Novartis Pharma, Basel, Switzerland
Matthew H. MacConnell, Air Products and Chemicals, Allentown, PA 
Rapti Madurawe, FDA,CDER,OPQ,OPF,DPAI, Silver Spring, MD
Jose Cardoso de Menezes, IST, UTL, Lisbon, Portugal
Sarah Pope Miksinski, AstraZeneca, Gaithersburg, MD
Christine M. Moore, Merck, West Point, PA
Fernando Muzzio, Rutgers University, New Brunswick, NJ
Moheb M. Nasr, Consultant
Justin Pritchard, Vertex, Boston, MA
G. K. Raju, Light Pharma, Cambridge, MA
Manoharan Ramasamy, Merck & Co., West Point, PA
Brian Rohrback, Infometrix, Inc., Bothell, WA
Saly Romero-Torres, Biogen, RTP, NC
Sonja S. Sekulic, Pfizer, Groton, CT 
Robert E. Sherman, ISA Life Fellow, Consultant, Shorewood, IL
Zhenqi (Pete) Shi, Eli Lilly, Indianapolis, IN
Tim Stevens, Bristol-Myers Squibb, New Brunswick, NJ
J.D. Tate, Dow Chemical, Freeport, TX
Gert Thurau, Hoffmann-LaRoche, Basel, Switzerland
Cenk Undey, Amgen, Thousand Oaks, CA
Juergen von Frese, Da-Sol, Utting am Ammersee, Germany
Tony Wang, Amgen, Houston, TX
Martin Warman, Martin Warman Consultancy, Swalecliffe, UK
Xiaoyu Zhang, Eli Lilly, Indianapolis, IN


Organization Representatives

Stephen Byrn, CPPR/PTCC/CAMP, Purdue University, West Lafayette, IN
James Drennen III and Carl Anderson, DCPT, Duquesne University, Pittsburgh, PA
Brian Marquardt, Director, CPAC, APL, Univ. of Washington, Seattle, WA
Antonio Moreira, University of Maryland - Baltimore County
Fernando Muzzio, Rutgers University, New Brunswick, NJ
Rodolfo Romañach, Ph.D., UPR, Mayagüez, PR,
Michael J. Tarlov, NIST, Gaithersburg, MD


IFPAC Director

Robert S. Zutkis, IFPAC, Grayslake, IL

Conference Management Software by X-CD Technologies Inc.